LYNETTE FOSTER: Open Payments
NPI 1851818082 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 25 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $265 |
| PFIZER INC. | 3 | $151 |
| Dexcom, Inc. | 4 | $145 |
| Inspire Medical Systems, Inc. | 2 | $122 |
| GENZYME CORPORATION | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Novo Nordisk Inc | 3 | $67 |
| Abbott Laboratories | 2 | $49 |
| Medtronic, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $24 |
Products named: NURTEC ODT, INSPIRE, FABRAZYME, REXULTI, DEXCOM G7 GSS (161), FREESTYLE LIBRE, Ozempic, Dexcom G6 Transmitter.
Industry payments across MO — which companies pay providers there.
